All Studies

Corrigendum: Bryophyllum pinnatum compounds inhibit oxytocin-induced signaling pathways in human myometrial cells.

Unfortunately, this abstract does not provide any information about the study or its findings as it only corrects the DOI of a previously published article. Without the original abstract or article, it is impossible to provide a summary for the general user.

Santos S et al (2023).
Front Pharmacol.
PubMed:
36843937

Neuroprotective and acetylcholinesterase inhibitory activities of alkaloids from Solanum lyratum Thunb.: An in vitro and in silico analyses.

Researchers extracted and isolated seven new alkaloids and 13 known alkaloids from the herb Solanum lyratum Thunb. They determined the structure of the new compounds and found that two of them, (-)-(7'S)-N-feruloyltyramine A and (+)-(7'R)-N-feruloyltyramine A, provided neuroprotective effects against cell damage and acetylcholinesterase inhibitory effects. The findings suggest that S. lyratum has potential as a source of new functional components for the pharmaceutical industry.

Chang Y et al (2023).
Phytochemistry.
PubMed:
36842735

Hydroxysafflor yellow a confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes.

Hydroxysafflor yellow A (HSYA) is a compound found in Carthamus tinctorius L. that has been shown to protect against neurological diseases, including traumatic brain injury (TBI). The methods and mechanisms behind HSYA's neuroprotective effects are not entirely understood.

Lai Z et al (2023).
J Ethnopharmacol.
PubMed:
36842723